Periactin and Heparin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Periactin (cyproheptadine hydrochloride) and Heparin (heparin sodium). Common drug interactions include chronic kidney disease among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Periactin and Heparin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Periactin?

Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,214 Periactin users. Check the latest studies of Periactin.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.



On Jul, 26, 2026

27 people who take Periactin and Heparin together, and have interactions are studied.

Periactin and Heparin drug interactions.

What are the common drug interactions of Periactin and Heparin, by gender? *:

female:

  1. Chronic kidney disease
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Haemoglobin decreased
  8. Headache (pain in head)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Pyrexia (fever)
  3. Device related infection
  4. Epistaxis (bleed from the nose)
  5. Factor ix inhibition (suppression of factor ix)
  6. Hypersensitivity
  7. Nephritis (inflammation of the nephrons in the kidneys)
  8. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

What are the common drug interactions of Periactin and Heparin, by age (0-1 to 60+)? *:

0-1:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Device related infection
  3. Epistaxis (bleed from the nose)
  4. Factor ix inhibition (suppression of factor ix)
  5. Hypersensitivity
  6. Nephritis (inflammation of the nephrons in the kidneys)
  7. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Air embolism

2-9:

  1. Hypertrichosis (hair growth on the body in an amount considered abnormal)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Impaired gastric emptying
  4. Impetigo (contagious skin infection)
  5. Influenza
  6. Leukocytosis (increased white blood cells)
  7. Lipase increased
  8. Lung disorder (lung disease)
  9. Lung neoplasm (tumour of lung)
  10. Mycoplasma infection (bacterial infection)

10-19:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Anastomotic leak
  3. Ileal stenosis (obstruction in the ileal)
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  7. Pain in extremity
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

  1. Nausea (feeling of having an urge to vomit)
  2. Aortic thrombosis (formation of a blood clot inside aorta)
  3. Appendicitis (inflammation of the appendix)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Chylothorax (collection of lymph fluid around the lung)
  6. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  7. Diarrhoea
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)

60+:

  1. Septic shock (shock due to blood infection)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Headache (pain in head)
  4. Heart rate increased
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypersensitivity
  7. Leukocytosis (increased white blood cells)
  8. Mouth haemorrhage (bleeding from mouth)
  9. Nausea (feeling of having an urge to vomit)
  10. Organ failure

What are the existing conditions these people have? *

  1. Immune Tolerance Induction: 5 people, 18.52%
  2. Fever: 5 people, 18.52%
  3. Nausea (feeling of having an urge to vomit): 4 people, 14.81%
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 11.11%
  5. Pain: 2 people, 7.41%
  6. Neoplasm Malignant (cancer tumour): 2 people, 7.41%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.41%
  8. Cystic Fibrosis (disease of the secretary glands): 2 people, 7.41%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Periactin and Heparin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Periactin and Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Periactin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Periactin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyproheptadine hydrochloride and heparin sodium (the active ingredients of Periactin and Heparin, respectively), and Periactin and Heparin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: